Immunovant, Inc. IMVT Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Immunovant, Inc.’s reported figures.
The official record: Immunovant, Inc.’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →
Ask your AI about Immunovant, Inc.'s enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Immunovant, Inc.'s enterprise value?
- Immunovant, Inc. (IMVT) reported enterprise value of $4.15B in Q1 2026.
- How has Immunovant, Inc.'s enterprise value changed year-over-year?
- Immunovant, Inc.'s enterprise value increased by 89.7% year-over-year, from $2.19B to $4.15B.
- What is the long-term trend for Immunovant, Inc.'s enterprise value?
- Over 5 years (2021 to 2026), Immunovant, Inc.'s enterprise value has grown at a 28.7% compound annual growth rate (CAGR), from $1.17B to $4.15B.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.